ErbB receptor negative regulatory mechanisms: implications in cancer.

ErbB receptor negative regulatory mechanisms: implications in cancer.

Item
http://www.wikidata.org/entity/Q36545883
Neuregulin-induced ErbB3 downregulation is mediated by a protein stability cascade involving the E3 ubiquitin ligase Nrdp1Neoadjuvant therapy for early-stage breast cancer: the clinical utility of pertuzumabThe ErbB4 receptor in fetal rat lung fibroblasts and epithelial type II cellsPost-transcriptional mechanisms contribute to the suppression of the ErbB3 negative regulator protein Nrdp1 in mammary tumors.Microbead arrays for the analysis of ErbB receptor tyrosine kinase activation and dimerization in breast cancer cellsSuppression of the negative regulator LRIG1 contributes to ErbB2 overexpression in breast cancer.The role of ErbB3 and its binding partners in breast cancer progression and resistance to hormone and tyrosine kinase directed therapies.LRIG1 negatively regulates the oncogenic EGF receptor mutant EGFRvIII.
P2860

ErbB receptor negative regulatory mechanisms: implications in cancer.

Item
http://www.wikidata.org/entity/Q36545883
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
ErbB receptor negative regulatory mechanisms: implications in cancer.
@ast
ErbB receptor negative regulatory mechanisms: implications in cancer.
@en
type
label
ErbB receptor negative regulatory mechanisms: implications in cancer.
@ast
ErbB receptor negative regulatory mechanisms: implications in cancer.
@en
prefLabel
ErbB receptor negative regulatory mechanisms: implications in cancer.
@ast
ErbB receptor negative regulatory mechanisms: implications in cancer.
@en
P1433
P1476
P2093
P2860
P2888
P304
P31
P356
P433
P478
P577
P698
P356
P1433
P1476
ErbB receptor negative regulatory mechanisms: implications in cancer.
@en
P2093
P2860
P2888
P304
P31
P356
P433
P478
P577
P698